GLS | Swing Trade

Zaktualizowano
📊 DETAILS
Sector: Pharmaceuticals & Drugs
Mkt Cap: 8,022 cr

Glenmark Life Sciences, a subsidiary of Glenmark Pharmaceuticals Ltd, is one of the leading developers and manufacturers of select high-value Active Pharmaceutical Ingredients. The company further operates in Contract Development and manufacturing operations to offer services to specialty Pharmaceutical companies.

TTM PE : 15.87 (High PE)
Sector PE : 48.06
Beta : 0.55

📚 INSIGHTS
MC Insights PRO
Stock with consistent financial performance, quality management, and strong technical momentum indicating good investor enthusiasm. Currently valued at Good to expensive valuation

3.00% away from 52 week high
Underperformer - Glenmark Life Sciences up by 3.14% v/s NIFTY 50 up by 8.32% in last 1 month

📈 FINANCIALS
Piotroski Score of 6/9 indicates Average Financials

Disclaimer: This analysis is for educational purposes only, and I'm not a SEBI registered analyst.
If you found this analysis helpful, I encourage you to like and share it. Your observations and comments are also welcomed below. Your support, likes, follows, and comments motivate me to consistently share valuable insights with you.

🔍 More Analysis & Trade Setups 🔍
For more technical analysis and trade setups, make sure to follow me on TradingView: tradingview.com/u/Munish_Jain/
Zlecenie aktywne
Transakcja zamknięta: osiągnięto wyznaczony cel
T1
Uwaga
Trail stoploss - 635
Transakcja zamknięta: osiągnięto wyznaczony cel
Zlecenie aktywne
Trail SL to 720
Transakcja zamknięta: osiągnięto wyznaczony cel
BANKNIFTYChart PatternsGLSTechnical Indicatorsinvestinginvestmentnifty50StocksstockstobuyswingtradingTrend Analysis

Wyłączenie odpowiedzialności